BioMarin to Host 2024 Investor Day on September 4th in New York

Rhea-AI Summary

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) has announced its upcoming Investor Day scheduled for September 4, 2024, in New York City. The event, running from 10:30 am to 1:00 pm Eastern Time, will be accessible via live webcast. Key highlights include:

• Presentations from executive management team
• Focus on BioMarin's pipeline and strategic plans
• Insights into growth opportunities
• Discussion of long-term financial outlook

Investors and analysts can access the webcast and presentation materials through the company's investor relations website. A replay will be available shortly after the event concludes, providing an opportunity for those unable to attend live to catch up on the important updates shared during the Investor Day.

News Market Reaction

+3.61%

1 alert

+3.61% News Effect

On the day this news was published, BMRN gained 3.61%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

-Event to be webcast live and a replay will be available

SAN RAFAEL, Calif., Aug. 19, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host an Investor Day with financial analysts and institutional investors on Wednesday, September 4, 2024, in New York City from 10:30 am to 1:00 pm Eastern Time.  The event will feature presentations from members of the executive management team and will highlight BioMarin's pipeline, strategic plans, growth opportunities and long-term financial outlook. 

BioMarin will host a live webcast on Wednesday, September 4, 2024, at approximately 10:30 am Eastern Daylight Time. Presentation materials will also be available at investors.biomarin.com. A replay of the webcast will be available online shortly after the live webcast is completed.

About BioMarin
Founded in 1997, BioMarin is a global biotechnology Company dedicated to transforming lives through genetic discovery. The Company develops and commercializes targeted therapies that address the root cause of genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The Company's distinctive approach to drug discovery has produced a diverse pipeline of commercial, clinical, and pre-clinical candidates that address a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a substantial benefit over existing treatment options. For additional information, please visit www.biomarin.com.

Contacts:
Investors	Media
Traci McCarty	Marni Kottle
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(650) 374-2803

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-host-2024-investor-day-on-september-4th-in-new-york-302224592.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When is BioMarin's 2024 Investor Day?

BioMarin's 2024 Investor Day is scheduled for Wednesday, September 4, 2024, in New York City from 10:30 am to 1:00 pm Eastern Time.

Will BioMarin's Investor Day be available online?

Yes, BioMarin (BMRN) will host a live webcast of the Investor Day on September 4, 2024, starting at approximately 10:30 am Eastern Daylight Time. A replay will also be available online after the event.

What topics will be covered at BioMarin's 2024 Investor Day?

BioMarin's 2024 Investor Day will cover the company's pipeline, strategic plans, growth opportunities, and long-term financial outlook. Presentations will be given by members of the executive management team.

How can investors access BioMarin's Investor Day materials?

Investors can access BioMarin's (BMRN) Investor Day presentation materials and webcast through the company's investor relations website at investors.biomarin.com.